↓ Skip to main content
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial
Published in
Blood Cancer Journal, April 2019
DOI 10.1038/s41408-019-0206-8
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 6 22%
Researcher 4 15%
Student > Master 2 7%
Lecturer > Senior Lecturer 1 4%
Lecturer 1 4%
Other 3 11%
Unknown 10 37%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 13 48%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Business, Management and Accounting 1 4%
Agricultural and Biological Sciences 1 4%
Economics, Econometrics and Finance 1 4%
Other 1 4%
Unknown 9 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2019.
All research outputs
#18,676,383
of 23,140,503 outputs
Outputs from Blood Cancer Journal
#928
of 1,113 outputs
Outputs of similar age
#266,044
of 352,672 outputs
Outputs of similar age from Blood Cancer Journal
#25
of 27 outputs
Altmetric has tracked 23,140,503 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,113 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.1. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,672 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.